Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention for Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol

Autoria(s): Lindholm, L.H.; Ibsen, H.; Dahlof, B.; Johnston, Dennis
Data(s)

01/03/2002
Identificador

http://pure.qub.ac.uk/portal/en/publications/cardiovascular-morbidity-and-mortality-in-patients-with-diabetes-in-the-losartan-intervention-for-endpoint-reduction-in-hypertension-study-life-a-randomised-trial-against-atenolol(7fd23430-172b-4533-9a60-92c1bd3fa411).html
Idioma(s)

eng
Direitos

info:eu-repo/semantics/restrictedAccess
Fonte

Lindholm , L H , Ibsen , H , Dahlof , B & Johnston , D 2002 , ' Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention for Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol ' The Lancet , vol 359 , pp. 1004-1010 .
Tipo

article
Acesso ao item digital